Omni Partners’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-233,924
Closed -$7.06M 35
2016
Q2
$7.06M Buy
+233,924
New +$4.75M 2.67% 13

Omni Partners's CPXX Position: Q3 2016 in Review

Omni Partners sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 233,924 shares — an estimated $7.06M sold.

Omni Partners first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $7.06M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Omni Partners reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Omni Partners sold 233,924 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $7.06M.
  • Omni Partners first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Omni Partners's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $7.06M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Omni Partners's 13F filing for Q3 2016, filed 14 Nov 2016.